SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TAMBORINO, Carmine
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.498
EU - Europa 2.309
AS - Asia 2.034
SA - Sud America 268
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 57
OC - Oceania 11
Totale 9.269
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.344
IT - Italia 1.407
SG - Singapore 801
CN - Cina 510
VN - Vietnam 211
BR - Brasile 205
DE - Germania 157
GB - Regno Unito 148
HK - Hong Kong 142
UA - Ucraina 133
TR - Turchia 107
FR - Francia 104
FI - Finlandia 95
CA - Canada 64
BD - Bangladesh 60
JP - Giappone 59
SE - Svezia 49
NL - Olanda 48
PL - Polonia 39
IN - India 38
RU - Federazione Russa 36
AT - Austria 32
MX - Messico 29
ZA - Sudafrica 27
ID - Indonesia 24
AR - Argentina 20
IQ - Iraq 20
CO - Colombia 14
HN - Honduras 12
BE - Belgio 11
CR - Costa Rica 11
CZ - Repubblica Ceca 11
PK - Pakistan 11
ES - Italia 10
VE - Venezuela 10
AU - Australia 9
UZ - Uzbekistan 8
GP - Guadalupe 7
KE - Kenya 7
MA - Marocco 7
DZ - Algeria 6
JM - Giamaica 6
PH - Filippine 6
PR - Porto Rico 6
TT - Trinidad e Tobago 6
EC - Ecuador 5
KR - Corea 5
SA - Arabia Saudita 5
AL - Albania 4
GT - Guatemala 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
CL - Cile 3
CW - ???statistics.table.value.countryCode.CW??? 3
EU - Europa 3
IL - Israele 3
IR - Iran 3
LT - Lituania 3
MD - Moldavia 3
MY - Malesia 3
PE - Perù 3
PY - Paraguay 3
RO - Romania 3
SV - El Salvador 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
BG - Bulgaria 2
BH - Bahrain 2
CH - Svizzera 2
DK - Danimarca 2
EG - Egitto 2
GR - Grecia 2
HU - Ungheria 2
LB - Libano 2
NI - Nicaragua 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BO - Bolivia 1
BW - Botswana 1
ET - Etiopia 1
GE - Georgia 1
GF - Guiana Francese 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
TC - Turks e Caicos 1
TW - Taiwan 1
Totale 9.186
Salva come PNG Salva come JPEG
Città #
Ashburn 620
Singapore 515
Woodbridge 337
San Jose 316
Fairfield 272
Houston 208
Chandler 193
Rome 180
Beijing 170
Santa Clara 161
Hong Kong 141
Jacksonville 138
Ann Arbor 136
Council Bluffs 136
Milan 104
New York 96
Seattle 91
Wilmington 91
Ferrara 87
Cambridge 83
Florence 81
Los Angeles 71
Ho Chi Minh City 69
Dallas 58
Tokyo 56
The Dalles 54
Nanjing 50
Hanoi 48
Izmir 46
Helsinki 43
Munich 43
Princeton 41
Boardman 40
Warsaw 37
Shanghai 36
Lauterbourg 32
Dearborn 30
Vienna 26
Buffalo 25
London 25
Bremen 22
San Diego 21
Atlanta 20
Addison 19
Orem 18
São Paulo 18
Turku 18
Mexico City 17
Nanchang 17
Phoenix 16
Toronto 16
Bologna 15
Cagliari 15
Chennai 15
Montreal 15
Turin 15
Brooklyn 14
Johannesburg 14
Naples 14
Chicago 13
Jiaxing 13
North Bergen 13
Shenyang 13
Jakarta 12
Taranto 12
Tianjin 12
Baghdad 11
Brussels 11
Denver 11
Frankfurt am Main 11
Hebei 11
Norwalk 11
Padova 11
San Francisco 11
Washington 11
Brno 10
Haiphong 10
Manchester 10
Montecatini Terme 10
Poplar 10
Reggio Emilia 10
Verona 10
Boston 9
Stockholm 9
Venice 9
Bari 8
Belo Horizonte 8
Changsha 8
Da Nang 8
Hefei 8
Redwood City 8
Terni 8
Amsterdam 7
Falkenstein 7
Hải Dương 7
Jinan 7
Prato 7
San José 7
Zhengzhou 7
Brescia 6
Totale 5.700
Salva come PNG Salva come JPEG
Nome #
Affidabilità delle mappe TC perfusionali nel definire il core infartuale e la penombra ischemica in pazienti con ictus ischemico acuto 1.504
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 284
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker 277
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 274
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 269
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 266
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 260
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 260
Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis 258
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 249
Adding blood to agitated saline significantly improves detection of right-to-left shunt by contrast-transcranial color-coded duplex sonography 247
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 240
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 232
Leptin/adiponectin ratio predicts post-stroke neurological outcome 232
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 223
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 215
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR THE IMPLEMENTATION A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES IN MS. 212
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 212
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 208
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 207
Relapsing-remitting neurological bladder as onset of immune-mediated vasculitis of spinal cord (MPO-ANCA) 203
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 201
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 194
Detection of Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response in a subset of patients with progressive forms of multiple sclerosis 193
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 192
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 187
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 186
Timing of Serum Soluble HLA-G Levels in Acute and Subacute Phases After Spontaneous Intracerebral Hemorrhage 183
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 182
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 174
MMP-9 isoforms in serum of Multiple Sclerosis patients 149
Effects of anticoagulants on the activity of gelatinases 140
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 134
Identification of circulating nonclassic human leukocyte antigen G (HLA-G)-dimer molecules in cerebrospinal fluids from MS stable patients. 121
Effects of anticoagulants on the activity of gelatinases 117
null 97
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 92
null 90
null 88
null 66
null 66
null 45
null 40
Totale 9.269
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.278
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022305 0 0 0 0 7 20 14 26 14 37 34 153
2022/2023803 43 66 26 84 113 79 63 66 106 29 60 68
2023/2024763 36 34 35 38 102 204 28 68 33 34 53 98
2024/20251.306 49 54 112 98 191 128 42 35 206 105 177 109
2025/20262.907 314 92 196 358 404 255 400 163 248 279 131 67
2026/2027827 70 136 288 306 27 0 0 0 0 0 0 0
Totale 9.269